Immunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: A randomized trial

Niyomnaitham S.Toh Z.Q.Licciardi P.V.Wongprompitak P.Srisutthisamphan K.Copeland K.K.Chokephaibulkit K.Mahidol University2023-06-182023-06-182022-10-01Journal of Infection Vol.85 No.4 (2022) , 436-48001634453https://repository.li.mahidol.ac.th/handle/20.500.14594/85499MedicineImmunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: A randomized trialLetterSCOPUS10.1016/j.jinf.2022.06.0142-s2.0-851372777971532274235728642